News & updates

2 October 2023

The Board of MCI is seeking a new CEO to drive forward the momentum achieved following their initial start-up period. The CEO will assume ownership of the current portfolio of work, leading the staff team and supporting the delivery of its many activities.

This will involve developing the newly formed clinical advisory group in conjunction with the Clinical Director, overseeing robust financial management, and nurturing the ongoing development of the small, high performing MCI team. The CEO will also lead the company through a review of MCI’s strategy thereby informing the development of a new organisational plan to support its purpose to transform cancer outcomes in Wales.

The successful candidate will demonstrate:

  • Established networks in healthcare, life sciences and commercial sectors in Wales and/or Welsh Government, and the ability to expand and extend those networks quickly.
  • Strong influencing and negotiating skills to work with partners and stakeholders, with the credibility and gravitas to engage with thought leaders and senior members of NHS Health Boards, the NHS Wales Executive, universities / educational establishments, Welsh Government, life sciences sector, industry, charities, and professional groups.
  • Proven track record in establishing an organisation’s strategy as well as the ability to be an effective, hands-on leader and team player.
  • You will be a high caliber, impactful and inspirational individual with well-honed commercial skills to spot market-ready innovations, developments or system changes that MCI could support the NHS to implement in cancer services.

For an informal and confidential discussion, please contact Aemilia Lovatt at Berwick Partners on the details below:

Aemilia Lovatt

Associate Partner, Private Healthcare

Berwick Partners

+44 (0) 207 518 2690 / +44 (0) 7793 266 959